跳至主要内容
临床试验/NCT06917339
NCT06917339招募中不适用

Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes

Neuronetics1 个研究点 分布在 1 个国家目标入组 156,000 人开始时间: 2025年2月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Neuronetics
入组人数
156,000
试验地点
1
主要终点
Change in clinical assessment score from baseline to post-treatment

研究概览

简要总结

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
5 Years 至 120 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female reported in database and not an invalid entry
  • Age reported and not an invalid entry
  • Treatment date of November 01, 2008 or later.

排除标准

  • Incomplete information on treatment parameters

研究组 & 干预措施

Patients treated with NeuroStar TMS

干预措施: NeuroStar Advanced TMS Therapy System (Device)

结局指标

主要结局

Change in clinical assessment score from baseline to post-treatment

时间窗: 8 weeks

real-world efficacy of NeuroStar TMS in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9

次要结局

  • Age at baseline and its correlation to change in score post treatment(8 weeks)

研究者

发起方
Neuronetics
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验